Sanofi Posts Higher 4Q Net Profit
04 Febbraio 2022 - 8:31AM
Dow Jones News
By Cristina Roca
Sanofi SA said Friday that net profit rose in the fourth
quarter, and that it expects its business earnings per share to
grow this year.
The French pharmaceutical company said that net profit came in
at 1.13 billion euros ($1.29 billion) for the period, up from
EUR1.07 billion for the same period last year.
Sales came in at EUR9.99 billion, up from EUR9.38 billion, the
company said. A consensus estimate provided by FactSet saw sales at
EUR10.4 billion for the quarter.
Business net income stood at EUR1.73 billion in the
October-December period, up 13% from the previous year, Sanofi
said.
Sales of Sanofi's growth driver Dupixent rose 53% on year in the
quarter at constant exchange rates, helping specialty care become
Sanofi's largest unit by sales.
For 2022, the company expects its business EPS to have low
double-digit growth at constant exchange rates, "barring unforeseen
major adverse events," it said.
Write to Cristina Roca at cristina.roca@wsj.com
(END) Dow Jones Newswires
February 04, 2022 02:16 ET (07:16 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Grafico Azioni Sanofi (EU:SAN)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Sanofi (EU:SAN)
Storico
Da Lug 2023 a Lug 2024